(Q46008893)

18 December 2017

title

How we treat Bowen's disease with topical photodynamic therapy in Dundee. (English)

1 reference

18 December 2017

1 reference

2

1 reference

18 December 2017

author name string

Sasi Kiran Attili

series ordinal

1

1 reference

18 December 2017

publication date

1 March 2009

1 reference

18 December 2017

Photodiagnosis and Photodynamic Therapy

published in

1 reference

18 December 2017

volume

6

1 reference

18 December 2017

issue

1

1 reference

18 December 2017

page(s)

41-45

1 reference

18 December 2017

Practice parameter: treatment of the child with a first unprovoked seizure: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Epilepsy after a first unprovoked seizure in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Risk of recurrent seizures after two unprovoked seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Vigabatrin in the treatment of epilepsy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Double-blind study of Gabapentin in the treatment of partial seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Lamotrigine extended-release as adjunctive therapy for partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Levetiracetam monotherapy in juvenile myoclonic epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

New antiepileptic drugs in pediatric epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Oxcarbazepine in the treatment of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Topiramate in patients with juvenile myoclonic epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Introduction to zonisamide

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Zonisamide treatment for symptomatic infantile spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

When antiepileptic drugs aggravate epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Nonpharmacologic treatment of the catastrophic epilepsies of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Levetiracetam in the treatment of Lennox-Gastaut syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

The first febrile seizure--antipyretic instruction plus either phenobarbital or placebo to prevent recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

The epidemiology of convulsive status epilepticus in children: a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

It's time to revise the definition of status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Intravenous levetiracetam in children with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

The use of levetiracetam in refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Neonatal seizures: multicenter variability in current treatment practices

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Clinical and EEG response to anticonvulsants in neonatal seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Phenobarbital compared with phenytoin for the treatment of neonatal seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Seizure-associated brain injury in term newborns with perinatal asphyxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Efficacy and tolerability of the ketogenic diet according to lipid:nonlipid ratios--comparison of 3:1 with 4:1 diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Long-term seizure outcomes following epilepsy surgery: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Occipital lobe epilepsy: clinical characteristics, surgical outcome, and role of diagnostic modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Surgical treatment of occipital lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Surgical outcome and prognostic factors of frontal lobe epilepsy surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Parietal lobe epilepsy: the semiology, yield of diagnostic workup, and surgical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Hemispherectomy for catastrophic epilepsy in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Surgical outcome of corpus callosotomy in patients with drop attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Multiple subpial transections in pediatric epilepsy: indications and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

The ketogenic diet: uses and abuses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

A multicenter study of the efficacy of the ketogenic diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

The outcome of children with intractable seizures: a 3- to 6-year follow-up of 67 children who remained on the ketogenic diet less than one year.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Ketogenic diet in patients with Dravet syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Thalamic and limbic involvement in the mechanism of action of vagus nerve stimulation, a SPECT study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Refractory generalized seizures: response to corpus callosotomy and vagal nerve stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

Vagus nerve stimulation, side effects, and long-term safety

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.6.1.41

21 January 2018

Identifiers

DOI

10.2217/14750708.6.1.41

1 reference

18 December 2017

1 reference

18 December 2017